文章内容就介绍到这里,更多关于慢病毒安全生产,安全使用的介绍可以阅读如下两篇文章: Rothe M, Modlich U, Schambach A. Biosafety challenges for use of lentiviral vectors in gene therapy. Curr Gene Ther. 2013;13(6):453–468. doi:10.2174/15665232113136660006; Sinn PL, Sauter SL, McCray PB Jr. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production. Gene Ther. 2005;12(14):1089–1098. doi:10.1038/sj.gt.3302570.